With bouyant buying and Christmas on the way, PBG is set for a great start in 2016. Sales already up 7% in the first 16 weeks with further growth on the way.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%